Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Physiol Cell Physiol ; 293(3): C885-96, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17553933

RESUMO

Plasma membrane Na(+)-K(+)-ATPase, which drives potassium into and sodium out of the cell, has important roles in numerous physiological processes. Cardiac steroids (CS), such as ouabain and bufalin, specifically interact with the pump and affect ionic homeostasis, signal transduction, and endocytosed membrane traffic. CS-like compounds are present in mammalian tissues, synthesized in the adrenal gland, and considered to be new family of steroid hormones. In this study, the mechanism of Na(+)-K(+)-ATPase involvement in the regulation of endocytosis is explored. We show that the effects of various CS on changes in endosomal pH are mediated by the pump and correspond to their effects on endosomal membrane traffic. In addition, it was found that CS-induced changes in endocytosed membrane traffic were dependent on alterations in [Na(+)] and [H(+)] in the endosome. Furthermore, we show that various CS differentially regulate endosomal pH and membrane traffic. The results suggest that these differences are due to specific binding characteristics. Based on our observations, we propose that Na(+)-K(+)-ATPase is a key player in the regulation of endosomal pH and endocytosed membrane traffic. Furthermore, our results raise the possibility that CS-like hormones regulate differentially intracellular membrane traffic.


Assuntos
Cardiotônicos/farmacologia , Endocitose/fisiologia , Ouabaína/farmacologia , ATPase Trocadora de Sódio-Potássio/metabolismo , Células-Tronco/enzimologia , Ácidos/metabolismo , Bufanolídeos/farmacologia , Cardiotônicos/metabolismo , Linhagem Celular , Membrana Celular/enzimologia , Digoxina/metabolismo , Digoxina/farmacologia , Endocitose/efeitos dos fármacos , Endossomos/enzimologia , Inibidores Enzimáticos/metabolismo , Inibidores Enzimáticos/farmacologia , Humanos , Concentração de Íons de Hidrogênio/efeitos dos fármacos , Neurônios/citologia , Ouabaína/metabolismo , Potássio/metabolismo , Transporte Proteico/fisiologia , Sódio/metabolismo , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , Células-Tronco/citologia , Transferrina/metabolismo , Trítio
2.
Mol Biol Cell ; 15(3): 1044-54, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14718569

RESUMO

Cardiac steroids (CSs) are specific inhibitors of Na+, K(+)-ATPase activity. Although the presence of CS-like compounds in animal tissues has been established, their physiological role is not evident. In the present study, treatment of human NT2 cells with physiological concentrations (nanomolar) of CSs caused the accumulation of large vesicles adjacent to the nucleus. Experiments using N-(3-triethylammonium propyl)-4-(dibutilamino)styryl-pyrodinum dibromide, transferrin, low-density lipoprotein, and selected anti-transferrin receptor and Rab protein antibodies revealed that CSs induced changes in endocytosis-dependent membrane traffic. Our data indicate that the CS-induced accumulation of cytoplasmic membrane components is a result of inhibited recycling within the late endocytic pathway. Furthermore, our results support the notion that the CS-induced changes in membrane traffic is mediated by the Na+, K(+)-ATPase. These phenomena were apparent in NT2 cells at nanomolar concentrations of CSs and were observed also in other human cell lines, pointing to the generality of this phenomenon. Based on these observations, we propose that the endogenous CS-like compounds are physiological regulators of recycling of endocytosed membrane proteins and cargo.


Assuntos
Membrana Celular/metabolismo , Núcleo Celular/metabolismo , Endocitose/efeitos dos fármacos , Esteroides/farmacologia , Transferrina/metabolismo , Bufanolídeos/farmacologia , Membrana Celular/efeitos dos fármacos , Núcleo Celular/efeitos dos fármacos , Células Cultivadas , Endocitose/fisiologia , Inibidores Enzimáticos/farmacologia , Humanos , Lipoproteínas LDL , Microscopia de Fluorescência , Miocárdio/metabolismo , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , ATPase Trocadora de Sódio-Potássio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA